Johnson & Johnson at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Johnson & Johnson takes part in 3 sessions at Antibody Engineering 2026 in San Diego. Its program covers animal-based antibody discovery, testing complex biologic drugs for developability, and a science talent award. Its research shows how a molecule's format shapes its physical behavior and how easily it can be developed into a medicine.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
Healthcare company whose Innovative Medicine segment develops antibodies, bispecifics and other medicines. | Talk Sun Dec 13 2:15pm–2:45pm Format Matters: Biophysical Characterization and Developability of Complex Biotherapeutics How a molecule's overall shape changes whether it can be made into a drug, across many measured antibody formats. Talk Mon Dec 14 10:55am–11:30am Chair Tue Dec 15 8:10am–8:15am |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction